| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 5.68e-06 | 3 | 28 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 5.68e-06 | 3 | 28 | 2 | GO:0009674 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 6.78e-05 | 9 | 28 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 2.55e-04 | 17 | 28 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 3.19e-04 | 19 | 28 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | acid-amino acid ligase activity | 4.71e-04 | 23 | 28 | 2 | GO:0016881 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 4.71e-04 | 23 | 28 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 6.04e-04 | 26 | 28 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 7.52e-04 | 29 | 28 | 2 | GO:0005540 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 2.50e-03 | 53 | 28 | 2 | GO:0016879 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 5.74e-03 | 81 | 28 | 2 | GO:0015370 | |
| Domain | Na/K/Cl_cotranspt | 2.17e-06 | 2 | 28 | 2 | IPR002443 | |
| Domain | AA_permease_N | 6.50e-06 | 3 | 28 | 2 | IPR013612 | |
| Domain | AA_permease_N | 6.50e-06 | 3 | 28 | 2 | PF08403 | |
| Domain | SLC12A_fam | 4.53e-05 | 7 | 28 | 2 | IPR004842 | |
| Domain | SLC12 | 6.03e-05 | 8 | 28 | 2 | PF03522 | |
| Domain | SLC12_C | 6.03e-05 | 8 | 28 | 2 | IPR018491 | |
| Domain | Xlink | 1.67e-04 | 13 | 28 | 2 | PF00193 | |
| Domain | LINK | 1.67e-04 | 13 | 28 | 2 | SM00445 | |
| Domain | LINK_1 | 1.67e-04 | 13 | 28 | 2 | PS01241 | |
| Domain | Link_dom | 1.67e-04 | 13 | 28 | 2 | IPR000538 | |
| Domain | LINK_2 | 1.67e-04 | 13 | 28 | 2 | PS50963 | |
| Domain | AA-permease/SLC12A_dom | 4.91e-04 | 22 | 28 | 2 | IPR004841 | |
| Domain | AA_permease | 4.91e-04 | 22 | 28 | 2 | PF00324 | |
| Domain | - | 5.33e-03 | 73 | 28 | 2 | 2.60.120.260 | |
| Domain | Galactose-bd-like | 8.70e-03 | 94 | 28 | 2 | IPR008979 | |
| Domain | - | 9.24e-03 | 97 | 28 | 2 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 9.61e-03 | 99 | 28 | 2 | IPR016186 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.53e-05 | 7 | 16 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 2.53e-05 | 7 | 16 | 2 | MM15081 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 9672238 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 16814616 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 7929272 | ||
| Pubmed | Increased Slc12a1 expression in β-cells and improved glucose disposal in Slc12a2 heterozygous mice. | 6.25e-07 | 2 | 28 | 2 | 26400961 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 8640224 | ||
| Pubmed | PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation. | 1.87e-06 | 3 | 28 | 2 | 30887444 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 8663127 | ||
| Pubmed | 2.28e-06 | 32 | 28 | 3 | 8895530 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 21972418 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 20819979 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 22989884 | ||
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 6.05e-06 | 44 | 28 | 3 | 27534441 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 1.74e-05 | 8 | 28 | 2 | 21613606 | |
| Pubmed | 1.74e-05 | 8 | 28 | 2 | 12386165 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 25993027 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 37827456 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 19323993 | ||
| Pubmed | 4.37e-05 | 497 | 28 | 5 | 23414517 | ||
| Pubmed | 6.52e-05 | 15 | 28 | 2 | 34048907 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 1.43e-04 | 22 | 28 | 2 | 18391953 | |
| Pubmed | DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy. | 1.98e-04 | 364 | 28 | 4 | 31391242 | |
| Pubmed | Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. | 3.25e-04 | 33 | 28 | 2 | 22904094 | |
| Pubmed | 3.45e-04 | 34 | 28 | 2 | 23926254 | ||
| Pubmed | 3.62e-04 | 173 | 28 | 3 | 23979707 | ||
| Pubmed | 4.09e-04 | 37 | 28 | 2 | 35918150 | ||
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | 5.13e-04 | 468 | 28 | 4 | 36042349 | |
| Pubmed | Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. | 7.48e-04 | 50 | 28 | 2 | 24769233 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 5.23e-03 | 177 | 28 | 2 | chr15q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 8.96e-03 | 234 | 28 | 2 | chr8p23 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#3_top-relative-expression-ranked_200 | 1.97e-06 | 69 | 28 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_200 | 2.34e-06 | 166 | 28 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#4_top-relative-expression-ranked_200 | 2.12e-05 | 41 | 28 | 3 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder urothelium (LCM)_emap-30380_k-means-cluster#1_top-relative-expression-ranked_500 | 5.73e-05 | 57 | 28 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder urothelium (LCM)_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_500 | 6.04e-05 | 58 | 28 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_500 | 2.00e-04 | 420 | 28 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.31e-04 | 91 | 28 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k2 | |
| ToppCell | ileum-Epithelial_Stem_Cells|ileum / shred on tissue and cell subclass | 6.67e-05 | 126 | 28 | 3 | a8ed48cbd1e207fd1aaad454fda9f329eb22aa83 | |
| ToppCell | Serous|World / shred by cell class for turbinate | 1.12e-04 | 150 | 28 | 3 | 6a326662d58b0f17d6efa8cc28571f4cbbf57c2d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 168 | 28 | 3 | 3e3f611e9bbec8224264666be14a4e7db343070e | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 169 | 28 | 3 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.59e-04 | 169 | 28 | 3 | 91f4b6a14708e701b2af22989004282041777491 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.59e-04 | 169 | 28 | 3 | 41cb92b0558f0d5a3e511058efd9110258b88ee3 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.62e-04 | 170 | 28 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 173 | 28 | 3 | 176b956e71d98e8275d698b39437fc326e5fe449 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-04 | 175 | 28 | 3 | bffa623511ceb0b9bf76d87f9a10cfadfe0e940f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 177 | 28 | 3 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 177 | 28 | 3 | f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.82e-04 | 177 | 28 | 3 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 180 | 28 | 3 | 0b653b1b653b40f3b8711d1312029a4a8a4961db | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.92e-04 | 180 | 28 | 3 | 52e76709fa95a884ac5d910b83bd173616dac340 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-04 | 184 | 28 | 3 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.04e-04 | 184 | 28 | 3 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.04e-04 | 184 | 28 | 3 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.04e-04 | 184 | 28 | 3 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.04e-04 | 184 | 28 | 3 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.04e-04 | 184 | 28 | 3 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Degenerative_Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-04 | 185 | 28 | 3 | d1cfca6e85fa767253de7e8a14621989b816635f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.08e-04 | 185 | 28 | 3 | 0acd8717ffbfb219664452a0947427eaa8b2a62a | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 2.18e-04 | 188 | 28 | 3 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 2.18e-04 | 188 | 28 | 3 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | COVID-19-Heart-Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 189 | 28 | 3 | 2586f4088721c5debec86c2b211b739fd33713eb | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.25e-04 | 190 | 28 | 3 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 192 | 28 | 3 | 967122c53af25b8f19a8411b4553d764c8d51c4d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.35e-04 | 193 | 28 | 3 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.39e-04 | 194 | 28 | 3 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-04 | 195 | 28 | 3 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | (01)_IL1RL1+-(1)_GFP|(01)_IL1RL1+ / shred by cell type by condition | 2.46e-04 | 196 | 28 | 3 | b598b1112242534e139318012b257ed3cb09da83 | |
| ToppCell | 10x5'v1-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 2.46e-04 | 196 | 28 | 3 | 31229affb48521e8be93b6061178fd8cea09ba99 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 2.46e-04 | 196 | 28 | 3 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 2.46e-04 | 196 | 28 | 3 | 15397ec27167bb2fb6fec120b68bf38fc71b2670 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.46e-04 | 196 | 28 | 3 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | MS-mono1|MS / Condition, Cell_class and T cell subcluster | 2.50e-04 | 197 | 28 | 3 | 32be48ee2a1397ed8f1ee8e60067dd9a96bece39 | |
| ToppCell | MS-mono1-|MS / Condition, Cell_class and T cell subcluster | 2.50e-04 | 197 | 28 | 3 | 4b038a193ecc1df65bcb608091c513ddafd6c818 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 198 | 28 | 3 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | VE-mono1-|VE / Condition, Cell_class and T cell subcluster | 2.54e-04 | 198 | 28 | 3 | 2959d6e4992c36040ec9637f5a2daed02b35cf30 | |
| ToppCell | VE-mono1|VE / Condition, Cell_class and T cell subcluster | 2.54e-04 | 198 | 28 | 3 | c742871b8ec4720b1848991551c7c1f4000ebd85 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 2.54e-04 | 198 | 28 | 3 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-04 | 198 | 28 | 3 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-04 | 198 | 28 | 3 | 6b18e18ed88b6043d6a18bd0f4264ec785781e57 | |
| ToppCell | Control-CD4+_T|Control / Disease group and Cell class | 2.54e-04 | 198 | 28 | 3 | 2682eea9b34cfc7e82891c1f1117d3c874107af6 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 2.54e-04 | 198 | 28 | 3 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-04 | 198 | 28 | 3 | 2e470249edc7cf85bed550795ff84cbef22895c0 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.57e-04 | 199 | 28 | 3 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | moderate-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.57e-04 | 199 | 28 | 3 | 3895e367a33ac0316f96a64c07574de99684f4b7 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.57e-04 | 199 | 28 | 3 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | PBMC-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 2.57e-04 | 199 | 28 | 3 | ebf03979ef56e978d72db475bb635b43b9cbe402 | |
| ToppCell | (04)_Interm._basal>secr.-(1)_GFP|(04)_Interm._basal>secr. / shred by cell type by condition | 2.57e-04 | 199 | 28 | 3 | 7a0d40d4679dc373829d67693851428f41c8b0d6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 199 | 28 | 3 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | control-Myeloid-CD14_Monocytes_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.61e-04 | 200 | 28 | 3 | 6defe58adacae88a16c59506a2029d98173ada71 | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 2.61e-04 | 200 | 28 | 3 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | mild-Myeloid-CD14_Monocytes_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.61e-04 | 200 | 28 | 3 | 837d326e4e47362dfd467c02b90cca0de90452fd | |
| ToppCell | Influenza|World / Disease, condition lineage and cell class | 2.61e-04 | 200 | 28 | 3 | df996c35907a1c9194b9e2ca30e81f520ca067f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Macroglial-Glia_progenitor_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 28 | 3 | fc9e2094f4d22412e3dd79e79649a6d46d62caec | |
| Drug | bromide;iodide | 4.37e-06 | 3 | 28 | 2 | CID009907214 | |
| Drug | Quinethazone | 1.46e-05 | 5 | 28 | 2 | DB01325 | |
| Drug | Bumetanide | 1.46e-05 | 5 | 28 | 2 | DB00887 | |
| Drug | Potassium Chloride | 2.18e-05 | 6 | 28 | 2 | DB00761 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 6.73e-05 | 13 | 28 | 2 | C1846647 | |
| Disease | Rheumatoid Arthritis | 5.92e-04 | 174 | 28 | 3 | C0003873 | |
| Disease | suicide | 1.03e-03 | 50 | 28 | 2 | EFO_0007624 | |
| Disease | hypertension (biomarker_via_orthology) | 1.28e-03 | 227 | 28 | 3 | DOID:10763 (biomarker_via_orthology) | |
| Disease | pyroglutamine measurement | 1.39e-03 | 58 | 28 | 2 | EFO_0005408 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VGKGFPWVEVAQVVK | 56 | Q6P047 | |
| VKVGAIQRWLKGQGV | 136 | P30040 | |
| LLVVGAGGVSKKFVW | 396 | A5YM72 | |
| WAAVFGGGVKLVVKP | 2381 | Q8TDJ6 | |
| ELGLVTQGGKVIWGK | 226 | O95478 | |
| LGKGQVIKAWDIGVA | 81 | Q13451 | |
| CGKNGVGVLIWKVPV | 106 | Q9Y5Y7 | |
| IVWKKTFIQGGQVSL | 266 | O95665 | |
| EKAGGVGPVQKFVTW | 506 | Q9H5P4 | |
| QKTAVWGGQEVKQGI | 616 | Q6ZU52 | |
| GFFKKGDVVIVLTGW | 501 | P14618 | |
| GVGKSVLVGNINIWI | 186 | Q8TCJ0 | |
| EVQGKGGVWKVIFKT | 81 | Q9UL42 | |
| MGILVVGGVVWKAVG | 616 | O95140 | |
| VQVWLGANGKVAVIV | 5346 | Q9Y6R7 | |
| VEKIAWQKGGIFKQG | 236 | Q05932 | |
| KVWVQAFKVEGGQFG | 356 | P11279 | |
| LKLEGWEKGVVFING | 566 | Q8IW92 | |
| IAKVGQIFAAWKILG | 286 | P10915 | |
| KLLVVAGASVGAGVW | 51 | Q9H7F4 | |
| GIVGGKNTVVAIAVW | 431 | Q969Y0 | |
| QAGVVKFGWVKGVLV | 171 | Q13621 | |
| WGLVKGAEITGKAIQ | 436 | Q8N0X7 | |
| GVVKFGWIKGVLVRC | 281 | P55011 | |
| VGKVIGIAIMKHFGW | 226 | Q9BTF0 | |
| FGKFQGKTVTIWEII | 3051 | Q15149 | |
| VKFQVGDLVWSKVGT | 266 | Q9BZ95 | |
| VWQKGITGKGVVITV | 151 | P29120 |